EO: radical transparency about wasteful spending. Synthesis and distribution of drugs of abuse and related compounds. June 9, 2025 - june 8, 2026. Task order 75N95025F00001 (TO8). N01DA-22-8944.
Active Awarded Last action
- Contract number
- 75N95025F00001
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,960,606
Award facts
- Opportunity
-
- 75N95025F00001 Solicitation number
- Contract value 100% obligated
- $1,960,606.00 Current and potential, with all options
- Completion date 69% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,960,606 |
About this award
The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, awarded a delivery order valued at $1.96 million to Research Triangle Institute (RTI International) for the synthesis and distribution of drugs of abuse and related compounds. This task order (TO8, N01DA-22-8944) runs from June 9, 2025 through June 8, 2026, with an ultimate completion date of June 8, 2027, and utilizes a cost-plus-fixed-fee pricing structure with no set-aside designation. The work will be performed at RTI's headquarters in Research Triangle Park, North Carolina. This delivery order is issued under NIDA's existing $19.9 million Indefinite Delivery Contract for the preparation and distribution of research drug products, which extends through March 2029 and enables NIDA to efficiently procure specialized pharmaceutical research support services.
RTI International, a prominent nonprofit research organization with extensive experience supporting federal agencies since 2001, brings substantial capabilities in pharmaceutical research and drug synthesis to this engagement. NIDA utilizes such research drug products to support its portfolio of intramural and extramural research on substance use disorders, addiction treatment, and related neuroscience investigations. RTI's existing work with NIDA and other National Institutes of Health components demonstrates the organization's established expertise in preclinical research services and specialized pharmaceutical preparation, positioning it to effectively deliver the synthesized compounds and distribution services required to support the Institute's research mission.
Quick answers
Who was awarded contract 75N95025F00001?
75N95025F00001 was awarded to Research Triangle Institute by National Institute on Drug Abuse (National Institutes of Health) on June 9, 2025.
How much is contract 75N95025F00001 worth?
The government has obligated $1,960,606 on 75N95025F00001.
Is contract 75N95025F00001 an order under another contract?
Yes. 75N95025F00001 is a delivery order under 75N95022D00016, an indefinite delivery contract.
Was contract 75N95025F00001 competed?
The extent of competition for 75N95025F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award